Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Funding for this research was provided by:
Daiichi Sankyo Co., Ltd.
Text and Data Mining valid from 2019-11-08
23 August 2019
8 November 2019